Article ; Online: Clinical severity of Gitelman syndrome determined by serum magnesium.
American journal of nephrology
2014 Volume 39, Issue 4, Page(s) 357–366
Abstract: ... without hypomagnesemia in order to determine whether serum magnesium concentration indicates the severity of the disease ... rare in GS. Serum magnesium may indicate the severity of GS. ... Background/aims: Normomagnesemia is considered atypical in Gitelman syndrome (GS). Here ...
| Abstract | Background/aims: Normomagnesemia is considered atypical in Gitelman syndrome (GS). Here, we describe clinical, pathological and genetic characteristics in Chinese GS patients with or without hypomagnesemia in order to determine whether serum magnesium concentration indicates the severity of the disease. Methods: 7 normomagnesemic and 25 hypomagnesemic GS patients who were confirmed by direct sequencing of SLC12A3 gene were included. Clinical manifestation and laboratory tests were documented. Supine and upright plasma renin activity, angiotensin II and aldosterone were determined by radioimmunoassay. Transient receptor potential channel melastatin subtype 6 (TRPM6) was detected by immunohistochemistry in paraffin-embedded renal biopsy sections of 12 GS patients. 14 patients with glomerular minor lesion served as controls. The distribution of the mutations on the predicted NCC protein was analyzed and compared between two subgroups. Results: Clinical manifestations, electrolyte abnormalities, metabolic alkalosis and renin-angiotensin-aldosterone system activation were found to be milder in normomagnesemic compared with the hypomagnesemic group. Compared with glomerular minor lesion controls, the TRPM6-positive area was significantly decreased in hypomagnesemic patients (4.96 ± 1.88 vs. 8.63 ± 2.67%) while it was near normal (7.82 ± 5.23%) in 2 normomagnesemic GS patients. A higher percentage of intracellular mutations was observed in normomagnesemic patients than hypomagnesemic patients (92.31 vs. 56.52%, p = 0.02). Conclusions: Normomagnesemia is not rare in GS. Serum magnesium may indicate the severity of GS. |
|---|---|
| MeSH term(s) | Adult ; Biomarkers/blood ; DNA Mutational Analysis ; Female ; Gitelman Syndrome/blood ; Gitelman Syndrome/genetics ; Humans ; Kidney/metabolism ; Magnesium/blood ; Male ; Middle Aged ; Renin-Angiotensin System ; Severity of Illness Index ; Solute Carrier Family 12, Member 3/genetics ; TRPM Cation Channels/metabolism ; Young Adult |
| Chemical Substances | Biomarkers ; SLC12A3 protein, human ; Solute Carrier Family 12, Member 3 ; TRPM Cation Channels ; TRPM6 protein, human ; Magnesium (I38ZP9992A) |
| Language | English |
| Publishing date | 2014 |
| Publishing country | Switzerland |
| Document type | Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 604540-6 |
| ISSN | 1421-9670 ; 0250-8095 |
| ISSN (online) | 1421-9670 |
| ISSN | 0250-8095 |
| DOI | 10.1159/000360773 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1635: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.